Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
53
53 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- RetatrutideLY3437943Phase 316 trials
Eli Lilly · Obesity, Overweight, Type 2 Diabetes
- BrenipatideLY3537031Phase 313 trials
Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major
- EloralintideLY3841136Phase 313 trials
Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2
- ZanzalintinibXL092Phase 311 trials
Exelixis · Colorectal Cancer, Renal Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
- OlomorasibLY3537982Phase 36 trials
Eli Lilly · Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis
- MazdutideLY3305677Phase 35 trials
Eli Lilly · Type 2 Diabetes, Obesity, Overweight
- MibavademabREGN4461Phase 35 trials
Regeneron · Generalized Lipodystrophy, Functional Hypothalamic Amenorrhea, FHA
- TersolisibLY4064809, STX-478Phase 33 trials
Eli Lilly · Breast Neoplasms, Neoplasm Metastasis, Breast Cancer
- TinlarebantLBS-008Phase 33 trials
Belite Bio, Inc · Stargardt Disease 1, STGD1, Geographic Atrophy
- AfimetoranBMS-986256, BLN-256Phase 32 trials
Beeline Medicines Corporation · Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus
- ClazakizumabLY5724886, CSL300Phase 32 trials
Eli Lilly · Atherosclerosis, Cardiovascular Disease, Obesity
- LepodisiranLY3819469Phase 32 trials
Eli Lilly · Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)
- VepugratinibLY3866288Phase 32 trials
Eli Lilly · Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3
- ATB-1011Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1012Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1013Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- B2227Phase 31 trial
Bostal Drug Delivery Co., Ltd · Schizophrenia
- RemternetugLY3372993Phase 31 trial
Eli Lilly · Alzheimer's Disease
- MORF-057zotemtegrast, LY4268989Phase 24 trials
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)
- antibioticsPhase 23 trials
TenNor Therapeutics (Zhongshan) Limited · Prosthetic Joint Infection (PJI), Periprosthetic Joint Infection (PJI), Acute Pyelonephritis
- LY4065967Phase 23 trials
Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee
- MacupatideLY3532226Phase 23 trials
Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2
- TL-925Phase 23 trials
Telios Pharma, Inc. · Allergic Conjunctivitis, Allergic Conjunctivitis of Both Eyes
- BimagrumabLY3985863, BYM338Phase 22 trials
Eli Lilly · Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction
- EltrekibartLY3041658Phase 22 trials
Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa
- LY188011Phase 22 trials
Eli Lilly · Neoplasms, Child, Adolescent
- LY3549492Phase 22 trials
Eli Lilly · Obesity, Overweight
- LY4005130Phase 22 trials
Eli Lilly · Alopecia Areata, Vitiligo, Non-Segmental Vitiligo (NSV)
- LY4395089Phase 22 trials
Eli Lilly · Crohn Disease, Colitis, Ulcerative
- Sutetinib MaleatePhase 22 trials
Teligene US · Non-small Cell Lung Cancer
- EI-001Phase 21 trial
Elixiron Immunotherapeutics (Hong Kong) Ltd. · Non-segmental Vitiligo
- EI-1071Phase 21 trial
Elixiron Immunotherapeutics Inc. · Mild, Moderate, or Severe Alzheimer's Disease
- EL219Phase 21 trial
Elion Therapeutics, Inc. · Invasive Mould Infection
- HP-002Phase 21 trial
Shanghai Helioson Pharmaceutical Co., Ltd. · B-Cell Non-Hodgkin Lymphoma
- HXN6005Phase 21 trial
Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)
- IVMED-85Phase 21 trial
iVeena Delivery Systems, Inc. · Myopia, Progressive
- KELI-101Phase 21 trial
Kelifarma · Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
- LY2784544Phase 21 trial
Eli Lilly · Neoplasms, Hematologic
- LY3457263Phase 21 trial
Eli Lilly · Type 2 Diabetes
- LY3537021Phase 21 trial
Eli Lilly · Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions
- LY3848575Phase 21 trial
Eli Lilly · Neuropathic Pain, Distal Sensory Polyneuropathy
- LY3871801Phase 21 trial
Eli Lilly · Rheumatoid Arthritis
- LY3938577Phase 21 trial
Eli Lilly · Diabetes Mellitus, Type 2
- LY3972406Phase 21 trial
Eli Lilly · Plaque Psoriasis
- LY4086940Phase 21 trial
Eli Lilly · Obesity, Overweight
- LY4100511Phase 21 trial
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company · Plaque Psoriasis
- LY4515100Phase 21 trial
Eli Lilly · Acute Pain, Molar, Molar, Third
- MerestinibLY2801653Phase 21 trial
Eli Lilly · Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer
- SolbinsiranLY3561774Phase 21 trial
Eli Lilly · Severe Hypertriglyceridemia
- TL-895Phase 21 trial
Telios Pharma, Inc. · Myelofibrosis, Primary Myelofibrosis, Post-PV MF
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.